SRW ENTERPRISES, INC. – Trademark Portfolio
Entity Type: 03
SRW ENTERPRISES, INC. has 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include COVERT and MEDSPEC PROTECT. The portfolio includes 2 registered trademarks. Filings span 7 Nice Classification classes, led by Class 12 (Vehicles) and Class 1 (Chemicals). This trademark owner is based in Bellevue, WA.
14015 S.E. 50th
Bellevue, WA 98006
Showing of trademarks Trademarks
Trademark Classifications
SRW ENTERPRISES, INC.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does SRW ENTERPRISES, INC. have?
SRW ENTERPRISES, INC. has 12 U.S. trademarks filed with the USPTO. Of these, 2 registered, 10 cancelled.
What trademark classes does SRW ENTERPRISES, INC. file in?
SRW ENTERPRISES, INC. files trademarks across 7 Nice Classification classes. The most active classes are Class 12 (Vehicles), Class 1 (Chemicals), Class 32 (Light Beverages), Class 35 (Advertising & Business), Class 10 (Medical Apparatus). Class 12 covers vehicles; apparatus for locomotion by land, air or water.
What are SRW ENTERPRISES, INC.'s most well-known trademarks?
SRW ENTERPRISES, INC.'s registered trademark portfolio includes well-known marks such as COVERT and MEDSPEC PROTECT. These are among 2 currently registered trademarks in the portfolio.
What is SRW ENTERPRISES, INC.'s trademark registration success rate?
SRW ENTERPRISES, INC. has a 17% trademark registration rate, with 2 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.